Green Alpha Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$385K Sell
2,569
-1
-0% -$109 0.26% 77
2026
Q1
$237K Sell
2,570
-290
-10% -$29.1K 0.23% 88
2025
Q4
$292K Sell
2,860
-1,546
-35% -$138K 0.27% 90
2025
Q3
$275K Sell
4,406
-1,088
-20% -$59.2K 0.27% 83
2025
Q2
$286K Sell
5,494
-1,436
-21% -$64.1K 0.27% 85
2025
Q1
$295K Sell
6,930
-155
-2% -$6.69K 0.32% 84
2024
Q4
$216K Sell
7,085
-1,697
-19% -$47.7K 0.17% 124
2024
Q3
$201K Buy
8,782
+1,674
+24% +$47.4K 0.16% 123
2024
Q2
$205K Buy
+7,108
New +$166K 0.16% 117
2024
Q1
Sell
-7,712
Closed -$209K 145
2023
Q4
$209K Sell
7,712
-2,398
-24% -$62.9K 0.15% 144
2023
Q3
$300K Buy
10,110
+2,724
+37% +$95.8K 0.23% 125
2023
Q2
$264K Buy
+7,386
New +$212K 0.17% 131
2023
Q1
Sell
-7,940
Closed -$216K 151
2022
Q4
$216K Sell
7,940
-167
-2% -$7.64K 0.18% 128
2022
Q3
$436K Buy
8,107
+2,046
+34% +$105K 0.37% 115
2022
Q2
$245K Buy
+6,061
New +$300K 0.06% 141

Other funds holding GH

Green Alpha Advisors's GH Position: Q2 2026 in Review

Green Alpha Advisors reduced its Guardant Health (GH) stake by 0.04% in Q2 2026, selling an estimated $109 and leaving 2,569 shares worth $385K. The position accounts for 0.26% of the portfolio, ranked #77.

Green Alpha Advisors first reported a position in GH in Q2 2022 and has held it in 15 quarters since. The position peaked at $436K in Q3 2022. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Green Alpha Advisors held 2,569 shares of Guardant Health worth $385K as of Q2 2026.
  • Green Alpha Advisors sold 1 Guardant Health share in Q2 2026, an estimated $109.
  • Guardant Health made up 0.26% of Green Alpha Advisors's portfolio in Q2 2026, its #77 holding.
  • Green Alpha Advisors first reported a position in Guardant Health in Q2 2022 and has held it in 15 quarters since.
  • Green Alpha Advisors's Guardant Health position peaked at $436K in Q3 2022.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.